Drugs / CART-TM4SF1
last change Nov 2021 re-read 3 minutes ago

CART-TM4SF1

Developed for
neoplasm
Investigated by
Shanghai Biomed-union Biotechnology Co., Ltd. · suhaichuan

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04151186 Nov 2019 → May 2021 neoplasm suhaichuan Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CART-TM4SF1 “the safety, tolerance, and preliminary efficacy of CART-TM4SF1 and CART-EpCAM cells will be examined” NCT04151186 ↗